Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9 - Wikidata - awgldk - TriplyDB

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

http://www.wikidata.org/entity/Q42276892

about

Potential role of herbal remedies in stem cell therapy: proliferation and differentiation of human mesenchymal stromal cells Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells Stromal cell-based immunotherapy in transplantation Differentiation of mesenchymal stem cells into gonad and adrenal steroidogenic cells Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models Mesenchymal stem cells as a gene delivery vehicle for successful islet transplantation.Bioengineering a highly vascularized matrix for the ectopic transplantation of islets Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on Osteopenia MMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells.Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment.Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction.Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.Mesenchymal stem cells as feeder cells for pancreatic islet transplants Umbilical cord-derived mesenchymal stem cells retain immunomodulatory and anti-oxidative activities after neural induction.Mesenchymal stem cells for inducing tolerance in organ transplantation Stem cell-based strategies for the treatment of type 1 diabetes mellitus Maintenance of islet morphology is beneficial for transplantation outcome in diabetic mice.Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction Cooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantation Mesenchymal stem cells facilitate mixed hematopoietic chimerism induction and prevent onset of diabetes in nonobese diabetic mice Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.The use of biomaterials in islet transplantation Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes.Genetically modified mesenchymal stem cells for improved islet transplantation Comparison of therapeutic characteristics of islet cell transplantation simultaneous with pancreatic mesenchymal stem cell transplantation in rats with Type 1 diabetes mellitus.HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.Mesenchymal stem cells for the treatment of diabetes Clinical operational tolerance after renal transplantation: current status and future challenges.Tolerance-inducing strategies in islet transplantation Mesenchymal stromal cells in renal ischemia/reperfusion injury.Controlled release strategies for modulating immune responses to promote tissue regeneration A preclinical evaluation of alternative site for islet allotransplantation.Comparisons of phenotype and immunomodulatory capacity among rhesus bone-marrow-derived mesenchymal stem/stromal cells, multipotent adult progenitor cells, and dermal fibroblasts.Preculturing Islets With Adipose-Derived Mesenchymal Stromal Cells Is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site.Mesenchymal stem cell-based therapy.

P2860

Q26741837-9F1CB4BD-C7D3-4F8E-B748-C0B8D24FD3AD Q26752205-9ECE2A81-9E72-40A2-B684-A8066A426C90 Q26851908-45843812-BBAD-47AE-B919-3542D384988D Q27003727-D2BF6A7D-0027-439E-AA7F-5453AC854875 Q27004008-2F436715-76EA-4513-91FC-66BFE3372A4C Q28085080-0A532BC1-5022-4486-8A4F-7366141209DD Q31006569-E3ADC3BC-83BE-4A32-83E9-F6AF3AEA86D9 Q33568319-43904116-3684-4507-B2F6-5C8F95C77F3B Q33588206-049CE824-19A6-451E-AB05-2D486B9F2541 Q33678477-61A2D5A0-2CB1-4F78-BFB6-30663751F5A0 Q33872942-FF121954-6D8F-41AA-B11A-3CED70B1E235 Q34097940-4F3E2F3A-D070-44F6-AD8C-926224EE640E Q34257083-4809C22C-FFB4-4D8A-A322-16D7C69A342B Q34292905-0B92AAD9-C0A2-4704-87A4-E4EFEECE6CC1 Q34340690-D25EB3F3-B988-40F5-95E1-3F58992C149C Q34358275-10971308-A576-4BE5-8350-1E3197F02518 Q34391029-9D775A53-33E0-4E45-BE3D-BC8E0C373849 Q34417324-4A32F0F0-0254-41D6-836C-D7DFE8ED63AF Q34603880-27403AC7-7A5D-4493-A263-AD4CDB3BC3D5 Q34873308-8558AE78-3172-469F-B303-3DB895A155E0 Q34979813-6BFA8081-4C2B-4C4E-B03B-A26159EC3C94 Q35112634-79A1CD2B-74F0-43CB-980C-8949F8F046E1 Q35137384-AFB10064-39D1-45D7-BF39-4F26D618B142 Q35196565-DA398F03-C2EB-4C69-B1B5-31BC1C93521B Q35227182-69D44096-4122-4248-9746-C27E6661E486 Q35256103-7D6C0607-C557-427D-A0D2-AC569B201315 Q35313985-18129C07-CD5D-4E32-B949-DF07D8FCE9D8 Q35660316-66287CE1-478E-467F-B675-039CA87D5979 Q35757109-0BF32CB9-1BE4-4975-89CF-FBC1681F1187 Q35861206-70CACFDC-49AF-4110-B01A-4FAF02B8F38B Q35866047-8762C4C3-94F4-49A8-944E-5BD988EC4385 Q35976665-3B24C7F0-3613-4CEA-977E-4B4A0B3E8BBE Q35991484-8076DE85-8D67-4604-922A-F38E7F7E9C8C Q36004707-566AA78C-14EE-4344-B28C-16D36C1DB4D6 Q36070565-2014D2F0-8C40-4BF4-AA95-7151031B1DBD Q36307642-A3F1530D-05E7-421E-9AC8-990C558A602C Q36328275-F280490F-FBF2-4E5D-A270-3C27856F1602 Q36424556-C1D4F29C-148A-46D3-BBC0-7EB437114CBD Q36523515-500E521E-13A7-4909-8051-FFBE2D101D47 Q36546424-3E61AE25-17B6-4615-B4B7-238FEE4A97AE

P2860

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

http://www.wikidata.org/entity/Q42276892

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9

@en

Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9

@nl

type

label

Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9

@en

Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9

@nl

prefLabel

Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9

@en

Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9

@nl

P1433

Q42276892-9D944082-C080-4B04-98E5-7BD6340D63A4

P1476

Q42276892-08FA85D4-131E-4183-AEA5-BB7106789B19

P2093

Q42276892-0AD0E58E-E352-4EC6-A8FA-3C699C4E402F

Q42276892-43CEEC46-6382-4D0D-9D33-DBE0036CC8BE

Q42276892-9A6A68AF-1F4F-4B94-ACB2-385CBC973C06

Q42276892-9B15C95F-F00F-4BAB-8DCC-AEB361285FC5

Q42276892-AB1A5D8D-B0A0-464D-9EDB-A6F34130955D

Q42276892-C0F8E30E-F6B2-4084-A08C-AAF49F5FBFC7

P2860

Q42276892-1419209E-5FA9-4E0D-B824-1EB9D2AC3534

Q42276892-1D53ECA6-64DD-4928-9BDF-43B519C5B96C

Q42276892-218C339B-AEBA-4CD3-AD3C-F79373CFE303

Q42276892-2785AA0E-7224-4EDB-B49F-256E2B3010FF

Q42276892-2F9C917D-0077-4170-B511-98864A5540A5

Q42276892-340CDED2-010A-442E-A6D8-26E97FCAC179

Q42276892-3627DBC2-A246-4E2C-96D5-C4FCB4BE6C96

Q42276892-4084356A-C270-4A81-AC33-A722D2FD5D18

Q42276892-43B8CCAF-8D3B-4454-A1A2-55D58C21CA60

Q42276892-4875535A-B012-4EE1-9D50-9AF6D92DA5DC

P304

Q42276892-5FE081F0-B118-43F4-ACA8-2ECBD0AFACD7

P31

Q42276892-48D298CC-2ADA-43D8-B52B-3128BF3B04AB

P356

Q42276892-98A92146-0160-461E-A99E-933FEB9BC511

P407

Q42276892-DC1E3336-9584-4913-B4C9-17FCDAD62BF4

P433

Q42276892-98F8F7D7-93D2-4EF9-AF4C-488534B88158

P478

Q42276892-CD06259E-BD37-4A05-9B06-6213A8E49C85

P577

Q42276892-E36908A3-1568-4883-A996-4DC311D43B70

P5875

Q42276892-3D0F015D-5923-4F66-A0F6-34E9E3CA64DB

P698

Q42276892-F37F6E5E-2892-480C-91F6-2B35F5CB6E66

P932

Q42276892-1A59F02F-4767-4D24-BE26-04B25D6FE3C1

P356

P1433

P1476

Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9

@en

P2093

Andrew Bushell

http://www.w3.org/2001/XMLSchema#string

Danmei Xu

http://www.w3.org/2001/XMLSchema#string

Gang Feng

http://www.w3.org/2001/XMLSchema#string

Kathryn J Wood

http://www.w3.org/2001/XMLSchema#string

Ruth J Muschel

http://www.w3.org/2001/XMLSchema#string

Yunchuan Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

Multilineage potential of adult human mesenchymal stem cells

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Adult rat and human bone marrow stromal cells differentiate into neurons

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

New functions for the matrix metalloproteinases in cancer progression

Matrix metalloproteinases and the regulation of tissue remodelling

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Marrow stromal stem cells

P304

1797-1806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB09-0317

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26278592

http://www.w3.org/2001/XMLSchema#string

P698

19509016

http://www.w3.org/2001/XMLSchema#string

P932

2712800

http://www.w3.org/2001/XMLSchema#string